Lastly, while our pathway-level analysis identified coherent enrichment patterns, further investigation into individual genes within leading edge subsets may help clarify which specific genes are most strongly associated with APP expression and whether they have functional roles in GBM progression or immune modulation and subsequent effects on clinical outcomes. The gene discussed is APP; the disease is glioblastoma.